Trial Details

COMPLETED
Basic Information
Clinical ID c3914
Identifier NCT01338740
Trial Title Switching From Adalimumab to Infliximab
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Crohn's Disease
Interventions DRUG: Adalimumab and Infliximab
Participant Information
Sponsor University Hospital, Ghent
City Antwerp
Country/Region Belgium
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2011-04
Primary Completion Date 2014-02-17
Completion Date 2014-02-17